Off-Label Use of Hospira Potassium Phosphate Injections On Infants Carries Aluminum Toxicity Risks: FDA Warns
The FDA is warning doctors not to prescribe Hospira potassium phosphate injections to infants, due to the risk of aluminum toxicity.
The FDA is warning doctors not to prescribe Hospira potassium phosphate injections to infants, due to the risk of aluminum toxicity.
Pfizer and Hospira have received an FDA warning letter over a YouTube video on the sedative Precedex which the FDA says did not include proper risk and indication information.
The Symbiq infusion pump may be vulnerable to hacking attempts that could lead to drug overdoses or lack of treatment, federal and company officials warn.
The FDA is warning that some Hosipra infusion pumps are susceptible to hacking.
The FDA is calling on the industry and healthcare groups to share data on cybersecurity vulnerability to plug holes before they are exploited.
The FDA is warning that electrical problems with Hospira's GemStar infusion pump docking station could lead to serious injuries or death.
The FDA warns that recalled Acclaim infusion pumps may cause overdoses or delay crucial medication therapy.
Hospira is recalling one lot of lidocaine injection because it could be contaminated with steel particles.
Hospira has announced a generic Reglan and generic Zofran recall due to potential glass contamination.
Another Hospira drug recall was announced this week after a customer found a human hair in Aminosyn injection fluid.